Extrafine HFA-beclomethasone-formoterol vs. nonextrafine combination of an inhaled corticosteroid and a long acting β2-agonist in patients with persistent asthma: A systematic review and meta-analysis.
<h4>Objective</h4>Airway inflammation in asthma involves not only the central airways but extends to peripheral airways. Lung deposition may be key for an appropriate treatment of asthma. We compared the clinical effects of extrafine hydrofluoroalkane (HFA)-beclomethasone-formoterol (BDP...
Guardado en:
Autores principales: | Ting Liu, Dan Yang, Chuntao Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0dda9bfe437a4e5595c0b24ca908691a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Use of concomitant inhaled corticosteroids: pooled data from two phase III studies of aclidinium plus formoterol in COPD
por: Anthony D’Urzo, et al.
Publicado: (2017) -
Comparison of Ipratropium Bromide and Beclomethasone in conservative therapy of asthma
por: Kh Bijani, et al.
Publicado: (2001) -
Dynamics of inhaled corticosteroid use are associated with asthma attacks
por: Joy Lee, et al.
Publicado: (2021) -
Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
por: Priyadarshini Kachroo, et al.
Publicado: (2021) -
The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis
por: Ian D. Pavord, et al.
Publicado: (2017)